NBIX - Neurocrine Stock Price

Brandmark of Neurocrine Corp (NBIX)

Neurocrine Biosciences (NBIX) develops cutting-edge medications for brain function correction, leveraging a diversified network of contractors to ensure stable supplies and high profitability. The commercial success of therapies for endocrine and neurological pathologies restores full activity to patients. This market price chart at the 165.96 level complements data on partnerships with global behemoths that accelerate the launch of new treatments through joint research.

NBIX - neurocrine.com Market Chart over the range 07/04/2022 - 11/18/2026

Neurocrine Biosciences Inc (NBIX) - metric breakdowns and financial figures

Analysis of all company metrics:neurocrine.com NBIX
Signature product of Neurocrine

The price reflects the market value of a single Neurocrine Biosciences (NBIX) share, determining the current business capitalization based on investors' willingness to pay for a stake in the company. The dynamics of this indicator serve as a portfolio stress-testing tool, identifying the margin of safety required to sustain the upward trend. Analyzing this price chart allows for the timely identification of deviations from the long-term course. The asset's value depends directly on the success of neurobiologists' developments. Colossal investments in treating brain diseases create the foundation for the stock's growth.

Analysis of competing companies

Stock Price BIIB|RGC (Regencell Bioscience Holdings Limited) - Price Performance Chart|Axsome Therapeutics - Stock Quotes|ACAD - Stock Quotes|XENE - Price Chart|Viking Therapeutics, Inc. - Price|Supernus Pharma (SUPN) - Price Chart|Share Price CPRX|Price Chart Denali Therapeutics|Share Price HRMY (Harmony Pharma)|Stock Price BHVN|AMLX - Market Price|trevitherapeutics.com - Stock Quotes|Stock Price Praxis Precision Medicines Inc PRAX|AVXL - Price Chart|Price Performance Chart CBLL (CeriBell EEG)|Prothena Corporation (PRTA) - Price Chart|Market Price Alector Inc. (ALEC)|ANNX (annexonbio.com) - Stock Price|Market Price omeros.com OMER|Stock Price NGNE|Stock Quotes AC Immune ACIU|Voyager Therapeutics Inc - Stock Quotes|Stock Price neumoratx.com NMRA|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel